HYPGENE-GENETICS FITNESS OBESITY & RISK OF HYPERTENSION
HYPGENE-GENETICS FITNESS OBESITY & RISK OF HYPERTENSION
批准号:
6845271
负责人:
Tuomo Rankinen
金额:
$31.71万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-16 至 2007-12-31
关键词:
aerobic exercisecardiovascular systemclinical researchcooperative studydisease /disorder prevention /controldisease /disorder proneness /riskessential hypertensionfamilial hypertensiongene environment interactiongene expressiongenetic polymorphismgenetic screeninggenetic susceptibilityhuman genetic material taghuman subjecthypertensionlongitudinal human studynucleic acid sequenceobesityphysical fitnesspolymerase chain reactionracial /ethnic differencesingle nucleotide polymorphismstatistics /biometry
中文摘要
描述(由申请人提供):HYPGENE研究是彭宁顿生物医学研究中心、库珀研究所和圣路易斯华盛顿大学共同努力的成果。本研究的目的是调查候选基因的DNA序列变异及其与心肺适能和肥胖的相互作用对有氧运动中心纵向研究(ACLS)参与者高血压风险的影响。在第一阶段(截至2003年12月1日),将从ACLS队列中挑选1000名在首次预防性体检时(1987年1月1日至2001年2月)血压正常且没有心血管疾病和糖尿病的受试者。这些受试者中有一半(n=500)在随访期间(持续2至16年)发展为高血压,而另一半保持正常血压。在第二阶段(从2003年12月至2005年11月),样本量将增加到1500名受试者(750例病例和750例对照)。病例被定义为基线时血压正常,但在随访期间发展为原发性高血压的个体。对照个体是那些在基线时血压正常,并在随访期间保持正常血压的人。病例对照状态的确定将在受试者回访库珀诊所期间进行。候选基因座的一组双等位单核苷酸多态将被分型。候选基因的选择是基于它们在与健康和肥胖有关的调节血压的生理途径中的假定作用,或者基于先前研究中的联系和关联的证据。候选基因包括促进血管扩张和收缩的内皮因子、介导自主神经系统对心脏功能和血管紧张性的影响的β-肾上腺素能受体及其激酶、肾素血管紧张素系统、以及介导层流切应力对血管壁酶活性和基因表达影响的信号分子。将使用Logistic回归模型和分类回归树方法来分析基因、健康水平和肥胖及其交互作用对高血压风险的贡献。HYPGENE的研究将产生新的数据,说明在心肺健康水平高或低,或者肥胖或正常体重的情况下,遗传因素对高血压发展的影响。这些数据最终可能导致在高血压的一级和二级预防中更有效地利用体力活动和体重控制。
英文摘要
DESCRIPTION (provided by applicant): The HYPGENE Study is a collaborative effort between the Pennington Biomedical Research Center, the Cooper Institute, and Washington University in St. Louis. The aim of the study is to investigate the contributions of DNA sequence variation in candidate genes as well as their interactions with cardiorespiratory fitness and obesity to the risk of hypertension in participants of the Aerobics Center Longitudinal Study (ACLS). In the first phase (as of 12/01/03), a group of 1000 subjects, who were normotensive and free of cardiovascular disease and diabetes at the time of their first preventive medical examination (from 01/1987 to 02/2001) will be selected from the ACLS cohort. Half of these subjects (n=500) developed hypertension during the follow-up period (duration 2 to 16 years), whereas the other half remained normotensive. In the second phase (from 12/03 to 11/05), the sample size will be increased to 1500 subjects (750 cases and 750 controls). Cases are defined as individuals who were normotensive at baseline but developed essential hypertension during follow-up. Comparison individuals are those who also were normotensive at baseline and remained normotensive during follow-up. The ascertainment of the case-control status will be done during the subjects' return visits to the Cooper Clinic. A panel of biallelic single nucleotide polymorphisms in candidate gene loci will be typed. The candidate genes are selected based on their putative roles in the physiological pathways pertaining to the regulation of blood pressure by fitness and obesity, or on evidence of linkages and associations in previous studies. The candidates include endothelial factors contributing to vasodilation and vasoconstriction, beta-adrenergic receptors and their kinases, which mediate the effects of autonomic nervous system on cardiac function and vascular tone, the reninangiotensin system, and signaling molecules that mediate the effects of laminar shear stress on vascular wall enzyme activity and gene expression. Logistic regression modeling and classification and regression trees methodology will be used to analyze the contribution of genotype, fitness level and obesity, as well as their interactions, to the risk of hypertension. The HYPGENE study will produce novel data on the effects of genetic factors in the presence of either high or low cardiorespiratory fitness level or obesity or normal body weight on the development of hypertension. These data could ultimately lead to more efficient use of physical activity and body weight control in the primary and secondary prevention of hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pennington MoTrPAC Adults
-
批准号:10391629
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2016
-
负责人:Tuomo Rankinen
-
依托单位:
Pennington MoTrPAC Adults
-
批准号:10265138
-
项目类别:
-
资助金额:$3.59万
-
财政年份:2016
-
负责人:Tuomo Rankinen
-
依托单位:
Pennington MoTrPAC Adults
-
批准号:10320475
-
项目类别:
-
资助金额:$237.5万
-
财政年份:2016
-
负责人:Tuomo Rankinen
-
依托单位:
Pennington MoTrPAC Adults
-
批准号:9246830
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2016
-
负责人:Tuomo Rankinen
-
依托单位:
HYPGENE-GENETICS FITNESS OBESITY & RISK OF HYPERTENSION
-
批准号:6997862
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2004
-
负责人:Tuomo Rankinen
-
依托单位:
HYPGENE-GENETICS FITNESS OBESITY & RISK OF HYPERTENSION
-
批准号:6727017
-
项目类别:
-
资助金额:$33.02万
-
财政年份:2004
-
负责人:Tuomo Rankinen
-
依托单位:
HYPGENE-GENETICS FITNESS OBESITY & RISK OF HYPERTENSION
-
批准号:7159332
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2004
-
负责人:Tuomo Rankinen
-
依托单位:
HERITAGE FAMILY STUDY, PHASE 4
-
批准号:7792493
-
项目类别:
-
资助金额:$69.09万
-
财政年份:1992
-
负责人:Tuomo Rankinen
-
依托单位:
HERITAGE FAMILY STUDY, PHASE 4
-
批准号:7574400
-
项目类别:
-
资助金额:$68.63万
-
财政年份:1992
-
负责人:Tuomo Rankinen
-
依托单位:
HERITAGE FAMILY STUDY, PHASE 4
-
批准号:7340187
-
项目类别:
-
资助金额:$66.82万
-
财政年份:1992
-
负责人:Tuomo Rankinen
-
依托单位:
海外基金